Results 21 to 30 of about 383,210 (284)

Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.

open access: yesCancer Discovery, 2020
Drugs targeting the cell cycle-regulatory cyclin-dependent kinase (CDK) 4 and 6 have been approved for the treatment of hormone receptor-positive breast cancer, and inhibitors targeting other cell-cycle CDKs are currently in clinical trials.
J. Chou   +4 more
semanticscholar   +1 more source

Cyclin-dependent kinase 1–dependent activation of APC/C ubiquitin ligase

open access: yesScience, 2016
Phosphorylation cues exit from mitosis The entry and exit from the cell cycle are controlled by waves of protein phosphorylation and degradation events. Fujimitsu et al.
K. Fujimitsu, M. Grimaldi, H. Yamano
semanticscholar   +1 more source

Palbociclib in breast cancer neoadjuvant setting

open access: yesAutopsy and Case Reports, 2021
Cyclin-dependent kinase 4/6 inhibitors represent a major advance in breast cancer treatment, emerging as the standard of care of the initial treatment of hormone receptor-positive and HER2-negative metastatic breast cancer.
Sílvia Alexandra Cabral Duarte   +3 more
doaj  

Regulation of signal duration and the statistical dynamics of kinase activation by scaffold proteins [PDF]

open access: yesPLoS Comput Biol. 2008 Jun 27;4(6):e1000099, 2008
Scaffolding proteins that direct the assembly of multiple kinases into a spatially localized signaling complex are often essential for the maintenance of an appropriate biological response. Although scaffolds are widely believed to have dramatic effects on the dynamics of signal propagation, the mechanisms that underlie these consequences are not well ...
arxiv   +1 more source

Prediction of kinase inhibitor response using activity profiling, in-vitro screening, and elastic net regression [PDF]

open access: yesBMC Systems Biology 2014, 8:74, 2013
Many kinase inhibitors have been approved as cancer therapies. Recently, libraries of kinase inhibitors have been extensively profiled, thus providing a map of the strength of action of each compound on a large number of its targets. These profiled libraries define drug-kinase networks that can predict the effectiveness of new untested drugs and ...
arxiv   +1 more source

Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells

open access: yesTumor Biology, 2018
Objectives: Preoperative chemoradiation is currently the standard of care in locally advanced rectal carcinoma, even though a subset of rectal tumors does not achieve major clinically meaningful responses upon neoadjuvant chemoradiation.
Girolamo Spagnoletti   +8 more
doaj   +1 more source

The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain

open access: yesViruses, 2015
Replication of human cytomegalovirus (HCMV) is characterized by a tight virus-host cell interaction. Cyclin-dependent protein kinases (CDKs) are functionally integrated into viral gene expression and protein modification.
Mirjam Steingruber   +7 more
doaj   +1 more source

Regulation of Sox6 by cyclin dependent kinase 5 in brain. [PDF]

open access: yesPLoS ONE, 2014
Cyclin dependent kinase 5 (Cdk5) is a proline-directed Ser/Thr kinase involved in various biological functions during normal brain development and neurodegeneration.
Parvathi Rudrabhatla   +3 more
doaj   +1 more source

Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics

open access: yesMolecular Pharmacology, 2015
Cyclin-dependent kinases (CDKs) have been considered promising drug targets for a number of years, but most CDK inhibitors have failed rigorous clinical testing.
Mary E. Law   +3 more
semanticscholar   +1 more source

Complexity in cancer biology: is systems biology the answer?

open access: yesCancer Medicine, 2013
Complex phenotypes emerge from the interactions of thousands of macromolecules that are organized in multimolecular complexes and interacting functional modules. In turn, modules form functional networks in health and disease.
Evangelia Koutsogiannouli   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy